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ABSTRACT
The activity of antithrombin (AT), a serpin protease inhibitor, is enhanced by heparin and heparin analogs
against its target proteases, mainly thrombin, factors Xa and IXa. Considerable amount of information is
available on the multistep mechanism of the heparin pentasaccharide binding and conformational acti-
vation. However, much of the details were inferred from ‘static’ structures obtained by X-ray diffraction.
Moreover, limited information is available for the early steps of binding mechanism other than kinetic
studies with various ligands. To gain insights into these processes, we performed enhanced sampling
molecular dynamics (MD) simulations using the Gaussian Accelerated Molecular Dynamics (GAMD)
method, applied previously in drug binding studies. We were able to observe the binding of the penta-
saccharide idraparinux to a ‘non-activated’ AT conformation in two separate trajectories with low root
mean square deviation (RMSD) values compared to X-ray structures of the bound state. These trajectories
along with further simulations of the AT-pentasaccharide complex provided insights into the mecha-
nisms of multiple conformational transitions, including the expulsion of the hinge region, the extension
of helix D and the conformational behavior of the reactive center loop (RCL). We could also confirm the
high stability of helix P in non-activated AT conformations, such states might play an important role in
heparin binding. ‘Generalized correlation’ matrices revealed possible paths of allosteric signal propaga-
tion to the binding sites for the target proteases, factors Xa and IXa. Enhanced MD simulations of ligand
binding to AT may assist the design of new anticoagulant drugs.
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1. Introduction
Antithrombin (AT), a plasma glycoprotein belonging to the ser-
pin superfamily, is one of the key regulators of coagulation cas-
cade (Quinsey, Greedy, Bottomley, Whisstock, & Pike, 2004).
Members of the serpin superfamily are found in all branches of
life (Rau, Beaulieu, Huntington, & Church, 2007). They include
inhibitors of serine and cysteine proteases, as well as non-
inhibitory proteins (Huntington, 2011; Whisstock & Bottomley,
2006). The serpins share a common tertiary structure, consisting
of eight alpha-helices and three beta-sheets as well as a solv-
ent-exposed reactive center loop (RCL) in their ‘native’ form
(Huntington, 2006; Whisstock & Bottomley, 2006). The protease
inhibition mechanism of the inhibitory serpins involves the for-
mation of a covalent complex with the protease (Huntington,
2011; Whisstock & Bottomley, 2006). The ‘trapping’ of the prote-
ase is accompanied by significant conformational changes of
the serpin, most importantly the insertion of the N-terminal
part of the partially cleaved RCL into beta-sheet A (Huntington,
2006; Whisstock & Bottomley, 2006).
Antithrombin inhibits multiple blood coagulation factors
with serine protease activity. Its main targets are thrombin
and the activated blood coagulation factors IX and X (FIXa
and FXa, respectively) (Muszbek, Bereczky, Kovacs, &
Komaromi, 2010; Rau et al., 2007). In its circulating, ‘native’
form, AT inhibits circulating proteases only at relatively low
reaction rates. The reaction rates of protease inhibition by
antithrombin are enhanced by heparinoids (Olson, Richard,
Izaguirre, Schedin-Weiss, & Gettins, 2010; Rau et al., 2007).
Two different mechanisms for the greater inhibitory activity
have been proposed (Olson et al., 2010). In the first mechan-
ism, binding of the ligand’s specific pentasaccharide
sequence to AT causes conformational changes. This
‘conformational’ activation plays a critical role in case of FIXa
and FXa, but its significance is limited in case of thrombin
(Olson et al., 2010; Rau et al., 2007). Alternatively, longer hep-
arin chains can form ‘bridges’ between antithrombin and the
protease, thus accelerating the formation of complexes. The
bridging mechanism is essential for enhanced thrombin
inhibitory activity (Olson et al., 2010). Heparin and its ana-
logues are important anticoagulant drugs, and their in vitro
effects on the inactivation of thrombin and FXa have been
subject of numerous studies. It has been proposed that AT
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could bind heparan sulfate chains at the endothelial wall,
therefore limiting blood coagulation when the blood vessel
wall is intact (Dinarvand, Yang, Villoutreix, & Rezaie, 2018;
Olson et al., 2010).
The conformation changes required for AT activation have
been subject of several studies. A three-step model has been
proposed for the heparin pentasaccharide binding and acti-
vation, involving two consecutive sets of conformational
changes (Olson et al., 2010; Roth et al., 2015; Schedin-Weiss,
Richard, & Olson, 2010). This mechanism is supported by X-
ray diffraction structures (Johnson & Huntington, 2003), kin-
etic studies of heparin binding and protease inactivation
(Schedin-Weiss et al., 2010) as well as by experiments with
engineered AT variants (Roth et al., 2015). In the first step,
the pentasaccharide forms relatively weak interactions with
the heparin binding site of AT, which then triggers conform-
ation changes, most significantly in the regions close to the
binding site (Desai, Petitou, Bj€ork, & Olson, 1998; Olson et al.,
2010). The second step involves rearrangements in the bind-
ing site as well as the hydrophobic core of the protein
(Langdown, Belzar, Savory, Baglin, & Huntington, 2009), while
the expulsion of the hinge region and the C-terminal exten-
sion of D helix in the third step leads to an even higher pro-
tease inhibitory activity (Belzar, Zhou, Carrell, Gettins, &
Huntington, 2002; Langdown et al., 2009; Olson et al., 2010).
X-ray diffraction structures of ‘native’ and fully activated AT,
as well as a structure showing AT in an intermediate acti-
vated state have been published (Johnson & Huntington,
2003; McCoy, Pei, Skinner, Abrahams, & Carrell, 2003). In this
intermediate structure, most of the conformational changes
involving the heparin binding site (with the exception of
helix D extension) and the hydrophobic core of the protein
have occurred (Johnson & Huntington, 2003). However, all
information related to the first step of pentasaccharide bind-
ing was obtained by means of kinetic studies, no X-ray struc-
ture exists for such an AT conformation.
Although the comparison of multiple AT X-ray diffraction
structures representing different conformations added useful
pieces of information to understand the allosteric mecha-
nisms, the X-ray structures still show a ‘static’ image of the
various states. Another limitation of these studies is that crys-
tal contacts can affect the conformation of the crystallized
protein. The size of AT still precludes the detailed structure-
function studies using nuclear magnetic resonance spectros-
copy (NMR), especially at an atomic resolution. In contrast
computational methods, including molecular dynamics (MD)
simulations have proven useful for studying conformational
changes and other biologically important processes in pro-
teins and other biomolecules at an atomistic level. Several
studies have been published in which MD-based methods
were applied to processes involving serpins, including AT.
Notable examples for such studies include modelling the
transition into latent conformation in plasminogen activator
inhibitor 1 at atomistic level (Cazzolli et al., 2014), the eluci-
dation of the pathway of RCL insertion in a1-antitrypsin
(Andersen et al., 2017), and protein folding studies aimed at
explaining the misfolding of mutated serpins (Wang et al.,
2018). Specifically, in case of AT, the role of Asn135
glycosylation (Pol-Fachin, Franco Becker, Almeida Guimar~aes,
& Verli, 2011) as well as the RCL dynamics and the conform-
ation of the critical Arg393 side chain was investigated (Toth,
Fekete, Balogh, Bereczky, & Komaromi, 2015). In a recent
study, the binding of D-myo-inositol-3,4,5,6-tetrakisphosphate,
a ligand with a scaffold different from heparinoids was
studied and signs of allosteric activation such as higher flexi-
bility of RCL were detected (Arantes, Perez-Sanchez, &
Verli, 2018).
However, one of the main limitations of ‘conventional’
MD remains its high computational cost. This makes the
modelling of the so-called ‘rare events’ challenging. To over-
come such ‘limitations,’ advanced sampling techniques have
been developed (Bernardi, Melo, & Schulten, 2015). Examples
of such advanced-sampling methods are replica exchange
(Sugita & Okamoto, 1999), umbrella sampling (K€astner, 2011),
metadynamics (Barducci, Bonomi, & Parrinello, 2011), adap-
tively biased MD (Babin, Karpusenka, Moradi, Roland, &
Sagui, 2009) and simulated annealing (Br€unger, Adams, &
Rice, 1997). The Gaussian Accelerated Molecular Dynamics
(GAMD) method, developed by Miao et al., offers advanced
sampling without requiring pre-defined reaction coordinates
or collective variables (Miao, Feher, & McCammon, 2015).
One of the main advantages of GAMD compared to the
related Accelerated Molecular Dynamics (AMD) technique
(Hamelberg, Mongan, & McCammon, 2004) is that it allows
free-energy calculations using reweighting that is often not
possible in case of AMD due to energetic noise ( Miao et al.,
2014, 2015 ). The GAMD method has proven useful in model-
ling of drug-binding pathways to multiple targets (Bhattarai
& Miao, 2018), including G-protein coupled receptors (Liao &
Wang, 2019; Miao, Bhattarai, Nguyen, Christopoulos, & May,
2018; Miao & McCammon, 2016) and the HIV protease (Miao,
Huang, Walker, McCammon, & Chang, 2018). GAMD provides
highly enhanced conformational sampling and has the
potential to provide realistic ligand binding pathway as it
does not depend on pre-defined reaction coordinates
(Bhattarai & Miao, 2018).
In the present work, we performed GAMD simulations to
investigate the ‘early’ events of the AT – pentasaccharide
binding, with idraparinux (Petitou & van Boeckel, 2004)
chosen as a pentasaccharide ligand. Only indirect informa-
tion exists for these early steps, based on kinetic studies with
modified pentasaccharides. The trajectories obtained in our
simulations revealed possible pathways concerning the bind-
ing of this molecule to AT. Furthermore, our simulations pro-
vided insights into the AT conformation changes triggered
by pentasaccharide binding.
2. Methods
2.1. System preparation
To study the binding of pentasaccharide to AT, we created
three model systems: an AT conformation without allosteric
activation, the same AT conformation with an added penta-
saccharide and AT-pentasaccharide complex. For the first
model system the 1T1F X-ray diffraction structure of native
AT was used (Johnson et al., 2006). Here, the structure of
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native AT was determined in a monomeric state, without a
bound pentasaccharide or a longer heparin chain.
The second model based on the same X-ray structure but
contained an added pentasaccharide (idraparinux). In a previ-
ous study, we have already investigated the conformation of
idraparinux in explicit solvent, using both Gaussian
Accelerated Molecular Dynamics and ‘conventional’ molecu-
lar dynamics simulations (Balogh et al., 2019). The initial
structure of the idraparinux molecule was built using the
‘NTP’ ligand found in the AT-pentassacharide complex X-ray
diffraction structure 1NQ9. Missing hydrogen atoms were
added using the OpenBabel software (O’Boyle et al., 2011). In
case of this ‘not activated’ AT with added ligand system, the
initial position of the pentasaccharide was determined using
least squares fitting of the AT conformation found in 1T1F
on the AT-pentasaccharide complex structure 1NQ9. After
the fitting, the ligand was shifted by 12Å along the vector
connecting the centers of masses between AT and the lig-
and. This resulted in a structure without any contact
between AT and pentasaccharide.
An X-ray diffraction structure of the partially activated AT
with a bound pentasaccharide (1NQ9) was used as the initial
structure for the AT-ligand complex system (third model sys-
tem) (Johnson & Huntington, 2003). Idrapariux was used as
ligand in this structure as well.
The ‘engineered’ amino acid substitutions in the X-ray
structures were mutated back and the missing loops in the
protein were built using MODELLER (Sali & Blundell, 1993).
The glycosylation of AT was modelled by adding disacchar-
ides consisting of two N-acetylglucosamine units to the AT
residues Asn96, Asn155 and Asn192. The three glycosylation
sites corresponded to those found in b-antithrombin
(Brennan, George, & Jordan, 1987; Quinsey et al., 2004). The
reason for using such truncated oligosaccharides was that
the appropriate sampling of the large and highly flexible gly-
cans would have been computationally very demanding.
The CHARMM carbohydrate force field was chosen for the
ligand (Guvench et al., 2011; Mallajosyula, Guvench, Hatcher,
& Mackerell, 2012), because this force field was found most
suitable for reproducing NMR data for the same molecule in
a previous study (Balogh et al., 2019). For the AT protein, the
CHARMM36m force field was applied (Huang et al., 2017).
The topology generation and the solvation steps of the sys-
tem preparation were performed using the CHARMM-GUI
webserver (Jo, Kim, Iyer, & Im, 2008; Lee et al., 2016; Park
et al., 2017). The model systems were solvated in a cubic
box. The ionic strength was set to approximately 0.15M by
adding the appropriate number of Naþ and Cl– ions.
2.2. Molecular dynamics and Gaussian accelerated
molecular dynamics simulations
We performed multiple ‘conventional’ MD and GAMD simula-
tions on the three model systems mentioned in the previous
section. The AMBER16 pmemd.cuda software was used in all
cases (Case et al., 2016; Le Grand, G€otz, & Walker, 2013;
Salomon-Ferrer, G€otz, Poole, Le Grand, & Walker, 2013). The
simulations in the present work are summarized in Table S1
(supplementary material).
Before the MD and advanced-sampling MD simulations,
energy minimization was performed. In the first 2000 steps
the steepest descents algorithm was applied, with position
restraint of 5 kcal/mol/Å on all non-solvent atoms. This was
followed by another minimization of 2000 steps without
restraints (500 steps steepest descents, 1500 steps conjugate
gradients). After minimization, the system was heated to
310 K in a 2 ns Langevin dynamics simulation. The heating
was followed by a 2 ns pressure equilibration MD using the
Berendsen barostat (Berendsen, Postma, van Gunsteren,
DiNola, & Haak, 1984). Position restraints of 2 kcal/mol/Å
were used on the protein and ligand atoms in the heating
and pressure equilibration steps. A 150-ns molecular dynam-
ics simulation under NPT conditions was performed in all
cases before the ‘production’ MD or GAMD. For the ‘non-acti-
vated’ AT (1T1F) with added pentasaccharide system, four
independent 150 ns conventional MD simulations were per-
formed, labelled A–D (Table S1). The ‘stochastic’ thermostat
used in the simulations resulted in divergent trajectories
even in the cases where identical initial conformation was
used. Two ‘starting’ conformations, A and B, were chosen for
further GAMD and conventional MD simulation, based on
the position of the pentasaccharide (see RMSD calculations
in the ‘MD trajectory analysis’ section and Figure S1, supple-
mentary material).
The ‘equilibration’ phase of the GAMD simulations was
60 ns long (Miao et al., 2015). The protocol of the equilibra-
tion step was similar to that used in our previous study of
idraparinux (Balogh et al., 2019). The first part of the simula-
tion was 10 ns conventional MD, in which energy data was
collected in the last 6 ns. In the following 50 ns part of the
simulations, GAMD boost potential was added and the
GAMD parameters were continuously updated (except
the first 5 ns). A ‘dual-boost’ GAMD scheme was applied and
the upper limits for both the potential and dihedral energy
boost SDs (r0) were set to 6.0 kcal/mol. Starting from the
equilibrated structures, two independent GAMD simulations
were performed in all cases: ‘native’ AT without ligand,
‘partially’ activated AT with ligand, as well as the two differ-
ent starting structures of ‘native’ AT with added idraparinux,
obtained by conventional MD. In the latter case, the simula-
tions were labelled A1, A2, B1 and B2 (Table S1). The
‘production’ simulations were performed under NVT condi-
tions at 310 K using a Langevin thermostat with collision fre-
quency of 2 ps1. The integration time step was 2 fs. The
long-range electrostatic interactions were treated using the
PME method (Darden, York, & Pedersen, 1993). The Coulomb
cutoff was set to 12 Å. A Lennard-Jones force switch was
used between 10 and 12Å. Bonds between heavy atoms and
hydrogens were constrained using the SHAKE algorithm
(Ryckaert, Ciccotti, & Berendsen, 1977). The atom coordinates
and the GAMD energies were saved every 0.1 ps to make
free energy calculations using GAMD reweighting possible.
Two of the four GAMD ‘ligand binding’ simulations,
where, as compared to the 1NQ9 structure, low RMSD values
of the ligand were observed, were expanded to 1000 ns.
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(Additional details of the RMSD calculations are found in the
‘Trajectory analysis’ section.) 600 ns equilibrium MD simula-
tions were also performed on all model systems as well. The
equilibrium MDs were performed under NPT conditions, but
all other parameters were identical to those used in GAMD.
2.3. Trajectory analysis
The CPPTRAJ program was used for trajectory analysis,
including calculation of distances, fluctuations and RMSDs
(Roe & Cheatham, 2013). With the exception of GAMD
reweighting, one snapshot was taken from every 100 ps of
the simulations for analysis. The ‘pentasaccharide RMSD’ was
calculated using the following two-step method: alpha car-
bon atoms in amino acids 6–26, 39–133, 137–355, 361–377,
402–431 of AT were fitted to the 1NQ9 X-ray diffraction
structure, and then the RMSD between the ring atoms and
the four glycosidic oxygen atoms was determined. Therefore,
the conformation of the rotatable side chains of the mol-
ecule was not taken into account. Protein secondary struc-
ture was analyzed using the DSSP method developed by
Kabsch and Sander (1983).
Representative conformations for the observed AT con-
formation changes were obtained by RMSD-based clustering
using the K-means algorithm, implemented in CPPTRAJ
(Figure S2, supplementary material). During the cluster ana-
lysis, fitting was performed first, using the same atoms as in
the pentasaccharide RMSD calculation. The RMSDs for all
non-hydrogen atoms in the regions analyzed (Helix D: resi-
dues 130-140, Hinge region: 375-385, RCL: 382-401) were
used as ‘distance metric.’ A different approach was used in
case of helix P: the trajectory was split into two parts at a
point when a conformational change occurred, and the low-
est RMSD frame compared to the average structures
were used.
GAMD reweighting was performed using the cumulant
expansion method as implemented in the PyReweighting
program ( Miao et al., 2014, 2015 ). Two-dimensional plots
from the reweighting results were created with the DPlot
software (https://www.dplot.com/index.htm). Allosteric path-
ways were studied using the ‘generalized correlation’ or
‘mutual information’ method, as implemented by Lange and
Grubm€uller in the g_correlation program (Lange &
Grubm€uller, 2005), based on an earlier work by Ichiye and
Karplus (1991). The UCSF Chimera software package was
used for visualization of protein structures (Pettersen
et al., 2004).
3. Results and discussion
3.1. Binding of the pentasaccharide ligand to
antithrombin
A three-step model has been proposed for the heparin pen-
tasaccharide binding and the subsequent conformational
changes, supported by kinetic studies and an X-ray diffrac-
tion structures showing AT in various pentasaccharide-bound
and ‘native’ states (Olson et al., 2010; Schedin-Weiss et al.,
2010). However, the mechanism for the earliest steps of
binding was mostly inferred from kinetic data (Olson et al.,
2010), no X-ray diffraction structure is available that would
correspond to a weak AT-pentasaccharide complex. In all
available ‘complex’ structures, AT exhibits either an inter-
mediate or fully activated conformation (Johnson &
Huntington, 2003; McCoy et al., 2003).
To study the early events of the binding of the pentasac-
charide at an atomistic level, we performed GAMD as well as
equilibrium MD simulations. The possible binding modes of
the ligands explored by the simulations are depicted in
Figure S3 (supplementary material). Here, one conformation
is shown for every 50 ns simulation time, colored according
to the RMSD compared to the 1NQ9 X-ray diffraction struc-
ture. From our four simulations in which ‘native’ AT with an
added pentasaccharide was investigated (labelled A1, A2, B1
and B2), we observed pentasaccharide binding in a conform-
ation comparable to X-ray diffraction in two of the four tra-
jectories, A1 and B1. This was demonstrated by RMSD values
< 2.5 Å for a significant period of time. In case of the B1 sys-
tem, this happened mostly in the 450–800 ns time interval,
while in the A1 trajectory, the change occurred at about
700 ns, and the ligand remained largely in the same position
until the end of simulation. However, in the other two
GAMD trajectories, as well as the equilibrium MD simulations
with the added ligand, this ligand-binding conformation was
not observed (see Figure S4, supplementary material).
The lowest-RMSD conformation among 1000 extracted
frames from these two trajectories is shown in Figure 1a. The
lowest RMSD snapshot from the last 100 ns part of the 1 ms
long 1NQ9 simulation, representing a similar binding state, is
also depicted. In Figure 1b, the three structures were super-
imposed so that their conformations can be compared to
the 1NQ9 structure. As expected, the positions of the penta-
saccharide in the three cases are remarkably similar to that
found in the X-ray structure. The differences were slightly
higher in the GH end of the idraparinux molecule than in
the DEF part.
To gain insight into the mechanism of the pentasacchar-
ide binding, we analyzed the RMSD values also for rings D, F
and H separately. These correspond to the non-reducing
end, the ‘middle’ and the reducing end of the molecule,
respectively. The RMSD data for all 12 simulations are shown
in Figures S5–S7 (supplementary material). There are import-
ant similarities between the binding mechanisms in trajecto-
ries A1 and B1 (Figure 2(a,b)). Most notably, the D and the F
rings must be positioned ‘correctly’ before ring H can reach
its binding site found in the X-ray diffraction structures.
These results agree with the previous proposal that the DEF
part of pentasaccharide molecule binds first, while strong
interaction with the GH part requires conformation changes
induced in the previous step of the process (Desai et al.,
1998). The sequence of events is different in the advanced
sampling simulation of the 1NQ9 system (Figure 2(c)). Here,
the binding of ring F does not precede ring H, but these
steps occurred in the reverse order. The 1NQ9 structure rep-
resents an ‘intermediate activated’ form of AT in which most
conformation changes around the heparin-binding site have
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taken place with the exception of D helix extension. Thus,
the binding site for ring H is already in a conformation that
can bind the GH end of the ligand with a high affinity.
The mechanism of pentasaccharide binding was further
examined by GAMD reweighting analysis. For all GAMD simu-
lations with pentasaccharide, this calculation was performed
using three pairs of reaction coordinates: the RMSD values
for ring D vs. ring F, ring D vs. ring H and ring F vs. ring H
(Figures S8–S10, supplementary material). Although the sam-
pling is probably insufficient for exact free energy calcula-
tions, some ‘qualitative’ conclusions can be still drawn from
the data. Most free energy surfaces obtained by reweighting
show that large part of the conformational space can be
explored by the system without any energy barrier higher
than 2 kcal/mol. A possible explanation for the relatively
small energy differences is that due to the flexibility of the
Arg and Lys residues, electrostatic interactions may still be
possible despite the RMSDs of one or more rings are some-
what higher.
Positively charged residues near the heparin binding site
of AT play a critical role in the interaction with the pentasac-
charide (Olson, Bj€ork, & Bock, 2002; Olson et al., 2010). The
three most important residues are Lys114, Lys125 and
Arg129, but Lys11, Arg13, Arg46 and Arg47 also make signifi-
cant contributions (Olson et al., 2002). We analyzed the dis-
tances between the negatively charged groups in the
pentasaccharide and the positively charged residues of the
heparin binding site. A cut-off value of 5 Å was used to dis-
criminate between conformations where the interaction was
present or absent (Figures 3 and S11, supplementary mater-
ial). For the binding data from all 12 simulations, see Figure
S11 (supplementary material). Our data demonstrate that the
ligand can interact with most basic residues even in confor-
mations where the RMSD is relatively high. Probably, this can
be explained by the high flexibility of the Arg and Lys resi-
dues. Even if most electrostatic interactions may be pre-
sented in the higher RMSD conformations, the interaction
energy is probably still lower than in the fully bound state,
because the AT-pentasaccharide interaction is known to have
a large hydrophobic component, and this component
depends on specific orientation of AT residues (Jairajpuri
et al., 2003).
The subunit G (iduronic acid) of the heparin pentasacchar-
ide can adapt different conformations: chair and boat-like. To
investigate the ring conformations during the simulation, we
have computed the Cremer-Pople theta parameter for all five
rings (Cremer & Pople, 1975). The ‘puckering’ data are shown
in Figure S12 (supplementary material). Significant conform-
ation changes were observed exclusively in the B1 simulation
and only in ring G. However, we have only observed minor
conformational flexibility in ring E where an alternative, boat-
like form was also present in our pentasaccharide-only
GAMD simulations (Balogh et al., 2019). The conformations of
rings D, F and H were remarkably stable in all simulations
and exclusively chair conformation was observed in all cases.
3.2. Conformational changes of antithrombin
The conformational changes of AT accompanying the penta-
saccharide binding have been grouped into two stages. The
first set of these changes corresponds to the induced-fit
events following the initial weak binding of the ligand.
Conformational changes mostly occur near the heparin bind-
ing site, the D-helix and the N-terminal part of the A helices.
The formation of the P helix near the N-terminal of the D-
helix is also considered to take place in the first step (Olson
et al., 2010). However, in the 1T1F X-ray diffraction structure
of AT, the molecule was captured in a native-like conform-
ation that contained an already formed P helix (Johnson
et al., 2006). In the next stage, the extension of the D helix
leads to locking of the hinge region in its expelled state. This
causes further increases of the heparin binding affinity and
protease inhibitory activity of AT.
Modelling of helix P formation is challenging, because the
insufficiency of the conformational sampling, even with
advanced sampling methods. This is supported by our two
‘preliminary’ GAMD simulations, based on the 1E04 (McCoy
et al., 2003) X-ray structure that does not contain this helix.
The DSSP analysis of these simulations showed no sign of
helix formation in this position (see Figure S13, supplemen-
tary material). As an alternative solution, we have chosen a
starting structure of native AT with a pre-formed helix P,
1T1F. To assess the stability of this secondary structural
element in our MD and GAMD simulations, we have
Figure 1. (A) Snapshots taken from the three 1-ms GAMD simulations representing ‘low RMSD’ conformations of the antithrombin-pentasaccharide complex. (B)
The three-binding modes were superimposed. The position of the ‘NTP’ ligand in the 1NQ9 X-ray diffraction structure is also shown for comparison (dark blue).
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Figure 2. ‘Sequential’ binding of the D, F, and H rings of the pentasaccharide in the A1 and B1 GAMD simulations. The H ring reaches its final ‘position’ after the D
and F ring has been correctly positioned. The mechanism is different in case of the 1NQ9 simulation. The method of the RMSD calculation for the entire ligand and
the specific rings is discussed in detail in the ‘Trajectory analysis’ section.
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performed DSSP analysis of this region. The helix was very
stable even in advanced sampling simulations, practically no
change occurred in this region in all but one trajectories. The
only exception is one of the two GAMD simulations of AT
without an activator (Figures 4(a) and S14, supplementary
material). Here an alternative conformation of the protein
backbone can be observed around Asn117. The DSSP data
also indicate that the secondary structure is no longer a-hel-
ical in this position.
The possibility of a conformation change near the C ter-
minal of the helix may provide information on the mechan-
ism concerning the formation of this structural element.
However, in the N-terminal part (amino acids 112–116) no
significant changes can be observed. Therefore, our observa-
tions do not contradict our hypothesis of the high stability
of this region. We could confirm the high stability of this
helix using an advanced sampling technique, proposed pre-
viously in a work from our group on the basis of conven-
tional MD simulations (Toth et al., 2015). The high stability of
helix P even in AT conformations without allosteric activation
suggests that this form may be in equilibrium with ‘native’
forms without such a structural element, and a significant
fraction of circulating native AT could adapt this conform-
ation. Based on these findings we suggest that ligand bind-
ing studies starting from a conformation with this helix may
provide biologically relevant data.
Recently, it has been proposed that the hinge region
expulsion takes place only in the last step of activation
(Olson et al., 2010; Roth et al., 2015). In contrast, Langdown
et al. (2009) suggested a rapid equilibrium between the
‘inserted’ and ‘expelled’ forms and emphasized the import-
ance of conformational changes of beta-sheet A that result
in ‘trapping’ of hinge region in the ‘expelled’ state.
The distance between the alpha carbon atoms of Val375
and Ser380 can be used to distinguish between the two con-
formational types for the hinge region. This parameter is
plotted as a function of time in Figure S15 for all 12 simula-
tions. Hinge region expulsion took place in all but two (B2
and one of the 1T1F simulations without ligand) GAMD
simulations (and also in one of the cMD simulations of the
1T1F system with a pentasaccharide.). Re-insertion of RCL’s
N-terminal end for a longer period of time was observed in
three trajectories, including the A1 and the expanded 1NQ9
simulation (Figures 5 and S15, supplementary material).
An important question is how the pentasaccharide bind-
ing affects the conformation of the hinge region. To deter-
mine the relative energies of the various hinge-region
inserted, expelled and intermediate states and to study the
effects of the ligand binding, we performed GAMD reweight-
ing. Free energies were calculated as a function of two reac-
tion coordinates: the RMSD of the pentasaccharide and the
Val375–Ser380 distance describing hinge region conforma-
tions (Figures 6(a) and S16, supplementary material). These
calculations were performed on all GAMD simulations con-
taining a pentasaccharide. Two further GAMD reweighting
calculations were performed that included all data points
from the four ‘1T1F with added pentasaccharide’ and the
two ‘1NQ9’ GAMD simulations (Figure 6(b)). Our results are
compatible with a model in which the hinge region expul-
sion can take place relatively easily in different states of acti-
vation. The closure of the beta-sheet A may be the critical
conformation change that is specific to the highest activation
state. Such closure of the sheet is evident in case of the 1-ms
simulation of the 1NQ9 system in Figure 5(c). As an alterna-
tive explanation, AT may have reached a fully activated state
with the hinge region expulsion. This seems unlikely in case
of the A1 and B1 systems, due to the lack of helix D exten-
sion. However, the final 150 ns part of the 1-ms 1NQ9 simula-
tion, where helix extension has taken place, may represent a
fully activated state of AT (Figure 4(b)).
Significant C-terminal extension of the D helix was
observed in only one trajectory, the 1-ms 1NQ9 simulation
(Figure S14, supplementary material). Here, according to the
DSSP data (Figure 4(b)) the C-terminal part of D helix did not
undergo any significant conformation changes in the first
part of the simulation. Significant helix extension could be
first observed at around 720 ns. Around the same time, a
decrease in the RMSD of the pentasaccharide can be seen in
Figure 3. Interactions (distance < 5 Å) between the negatively charged groups of the pentasaccharide and the basic residues of the AT heparin binding site, dur-
ing the three 1-ms simulations.
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Figure 2c. In the last 150 ns, the Ala134 amino acid was pre-
dicted to be part of the helix in around half of the simulation
time. This corresponds to a conformation in which the helix
is approximately one amino acid shorter than in the X-ray
diffraction structure 1E03 (McCoy et al., 2003), representing a
‘fully activated’ form.
Figure 4. (A) Conformation change of the P helix in one of the GAMD simulations without a pentasaccharide ligand. The DSSP analysis of the secondary structure
in the region 110–139 is depicted, along with ‘characteristic’ conformations from the trajectory (for the method of obtaining the representative structures, see the
‘Trajectory analysis’ section). The 1T1F X-ray diffraction structure (after modelling the missing loops and energy minimization) is also shown as a comparison. (B)
Extension of the D helix in one of the GAMD simulations, starting from the 1NQ9 X-ray diffraction structure. ‘Representative’ conformations were obtained by
means of clustering (see Figure S2A).
Figure 5. ‘Characteristic’ conformations of the ‘hinge region’ (the N-terminal end of the RCL) from the three 1-ms GAMD simulations. The V375.CA–S380.CA dis-
tance was used to distinguish between the various conformations. Low values (less than approximately 6 Å) correspond to the ‘inserted’ state. ‘Representative’ con-
formations were obtained by means of clustering (see Figure S2B).
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3.3. Conformation of the reactive center loop
The reactive center loop of the inhibitory serpins plays a cru-
cial role in the inactivation of target proteases. The import-
ance of conformational dynamics of this loop in the AT
protein has been emphasized in a previous paper form our
group (Toth et al., 2015). A significant number of X-ray dif-
fraction structures are available for the AT protein. However,
in many cases, the complex between a native and a latent
AT molecule was crystallized and its structure resolved. In
these dimeric X-ray diffraction structures, the RCL of the
native serpin molecule interacts with the latent AT. Thus,
such structures could provide only limited information on
the structure of this loop in a solution phase. In a latter X-
ray diffraction study, the structure of the native AT was suc-
cessfully determined that did not interact with a latent serpin
molecule. In this experiment, an AT variant with an engi-
neered disulfide bond was used that prevented the latent
transition of AT. In this structure (1T1F), the RCL of AT has
adopted a novel conformation compared to the previous
studies. In a previous work, long (2 ms) molecular dynamics
simulations of non-activated AT were performed and ana-
lyzed, representing both conformation types (Toth et al.,
2015). In the ‘conventional’ MD simulation, no transition
between the two forms could be observed. However, it was
demonstrated using a metadynamics simulation that this is
possible in at least one direction (Toth et al., 2015).
In the present work the Arg236–Ile390 distance was
chosen for comparing the various conformations as it can
separate the two major forms. In Figure 7, this distance is
plotted as a function of time, along with several
‘characteristic’ conformations from the three 1-ms trajectories.
‘Representative’ conformations were obtained using cluster-
ing (see Figure S2C, supplementary material). The time
evolution of the same parameter is presented for all 12 simu-
lations in Figure S17 (supplementary material).
At the beginning of both the A1 and B1 simulations, the
distance of the Arg236 and Ile390 alpha carbon atoms is well
below 15Å in most analyzed conformations. This corre-
sponds to a loop position comparable to that found in the
1T1F structure. At around 280 ns in the A1 and around
140 ns in the B2 simulation, a remarkable conformation
change occurs. From that point, in the A1 simulation various
RCL conformations can be observed, and the distance par-
ameter fluctuates remarkably. The distance values are
approximately in the same range as in the 1NQ9 trajectory,
derived from an X-ray structure with a different starting RCL
conformation. In contrast, the same parameter was relatively
stable in the last 800 ns part of the simulation B1. Regarding
the 1 ms simulation based on the 1NQ9 structure, the exist-
ence of large number of different RCL conformations can be
seen. However, conformations in the 15–18Å region were
only minimally sampled, and no RCL position resembling to
that found in the 1T1F structure could be observed. A solv-
ent accessible Arg393 residue, required for efficient inhibition
of target proteases, was present in a significant number of
structures from all three simulations.
However, conformational changes between the two major
conformational types are still ‘rare events’ even in the
advanced sampling simulations. In all trajectories analyzed,
either a single transition occurred in only one direction or no
such change was observed at all. To obtain a rough estima-
tion of the potential surface of the RCL conformations GAMD
reweighting calculations were performed (Figure S18, supple-
mentary material), using two reaction coordinates, the con-
formation of RCL and of the hinge region. Although – due to
insufficient convergence – there is uncertainty in the
reweighting data, the results are compatible with an energy
Figure 6. Two-dimensional plots of the results obtained by GAMD reweighting, using two reaction coordinates: RMSD of the pentasaccharide ring and backbone
atoms vs. V375.CA–S380.CA distance. (A) The results obtained from the three 1 ms simulations. (B) Two further GAMD reweighting calculations, including all data
from the four 1T1F and the two 1NQ9 simulations.
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barrier in the 15–20Å region. This energy barrier might slow
down the ‘mixing’ of the two conformational types (Figure S18,
supplementary material). Despite of the advanced sampling
method by significant computational efforts, however, the con-
formational sampling could have been still insufficient.
3.4. Root mean square fluctuations
Root mean square fluctuation (RMSF) is a frequently used
method to measure flexibility of various structural regions in
proteins from an MD trajectory. To study the changes in fluc-
tuation caused by the pentasaccharide binding, we have per-
formed RMSF calculations on all 12 ‘production’ simulations
(Figures 8 and S19–S21, supplementary material).
As reported previously (Toth et al., 2015), most AT residues
have relatively low root mean square fluctuations, especially
those that form helices or beta-sheets. Notable exceptions are
the RCL and the loops in the N-terminal region. These loops
are highly flexible, in agreement with the previously published
RMSF data from conventional MD simulations. Other regions
with higher than average RMSF values are the loop involved in
the D helix extension (residues 131–139), the loop at the C ter-
minal end of helix D (residues 191–210), some of the residues
close to the FXa binding site (amino acids 235–240) and a flex-
ible segment consisting of amino acids 355–365.
To investigate the effects of pentasaccharide binding on the
fluctuations, another set of RMSF calculations was carried out
for the three 1-ms simulations. Here only those parts were
included in the calculations where most of the conformations
with low pentasaccharide RMSD occurred: 640–1000ns for the
A1, 440–800ns for A2 and 720–1000ns for the 1-ms simulation
of the 1NQ9 system (compare Figure 2(a)–(c)).
Decreased fluctuations can be observed near the heparin
binding site (residues 110–140) in both the A1 and A2 simu-
lations. The decrease of RMSF near helices D and P may sug-
gest the stabilization of a conformation, which is more
suitable for binding the ligand. Further changes in RMSF can
be observed in case of residues 220–240. These changes are
more significant in case of the A1 simulation, but are also
clearly present in case of simulation B1. This region contains
multiple amino acids with a proposed role in AT-FXa exosite
interactions, namely Asn233, Arg235 and Glu237 (Izaguirre
et al., 2014). The decrease of RCL fluctuations may be surpris-
ing as increased RCL flexibility triggered by ligand binding
has been reported in the literature (Arantes et al., 2018). The
decrease of RCL fluctuation observed in our study could be
explained by the fact that RCL was highly flexible in our sim-
ulations and several of these conformations were excluded
from the analysis. The RCL remains, however one of the
most flexible structural elements of the protein.
3.5. Mechanism of allosteric activation
The investigation of allosteric pathways are essential for
understanding the conformational activation of AT. Multiple
proposals of possible pathways exist in literature. Both X-ray
Figure 7. ‘Characteristic’ conformations of the reactive center loop from the three 1-ms GAMD simulations. The K236.CA–I390.CA distance was used to distinguish
between the various conformations. Low values (5–16 Å) represent conformations similar to that found in the 1T1F X-ray structure. ‘Representative’ conformations
were obtained by means of clustering (see Figure S2C).
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Figure 8. Root mean square fluctuations (RMSF) of the a-carbon atoms, during the three 1 ms molecular dynamics simulations. The RMSF values calculated for the
whole trajectory are shown in blue. RMSF was also computed for parts of the trajectories where low-RMSD binding states of the pentasaccharide were most
‘typical’ (depicted in red). The backgrounds of the plots were colored according to the secondary structure of the region: orange for helices and blue for b-sheets.
Figure 9. Generalized correlation matrices for the three 1-ms GAMD trajectories, calculated using a method proposed by Lange and Grubm€uller (2005).
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diffraction structures (Huntington, 2011; Olson et al., 2010)
and MD-based studies (Arantes et al., 2018; Pol-Fachin et al.,
2011; Toth et al., 2015) have been used to investigate the
details of the allosteric processes. In our GAMD simulations,
we were able to capture a significant number of different
binding modes for the pentasaccharide, including conforma-
tions with relatively large RMSD compared to the X-ray struc-
tures. Therefore, it can be assumed that such advanced
sampling simulations may potentially reveal details of the
allosteric processes that would be difficult to obtain using
either X-ray crystallography data or ‘conventional’ MD
simulations.
From the molecular dynamics trajectories, we analyzed
the correlated motions between the alpha carbon atoms
using the ‘generalized correlation’ or ‘mutual information’
measure, developed by Lange and Grubm€uller (2006). A
Figure 10. A conformation change involving the N-terminal part of the D helix. The distance between the alpha carbon atoms of Thr85 (in helix B) and His120 cor-
relates with the binding mode of the pentasaccharide.
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significant advantage of this method over the probably more
common Pearson correlation coefficient calculations is that it
can also detect nonlinear correlations between specific
atoms of the proteins. The ‘generalized correlation’ matrices,
calculated for all 12 ‘production’ simulations, are depicted in
Figure S22 (supplementary material). The matrices for the A1
and the B1 systems as well as the 1 ms 1NQ9 simulations are
compared in Figure 9. Regarding the A1 simulation, interest-
ing correlated motions can be seen between two distant
parts of the protein: helix D and adjacent residues, critical for
heparin binding and the region consisting of the 230–310
amino acids. Many known exosite residues involved in FXa
and FIXa binding are found in the latter region: Asn233,
Arg235, Glu237, Tyr253 and Glu255 (Izaguirre et al., 2014;
Olson et al., 2010). Correlation was also detected between
helix D and the N-terminal part of reactive center loop, con-
firming the relationship between binding of the pentasac-
charide, hinge region expulsion and conformational changes
of RCL. A further region of AT that seems to be involved in
the allosteric processes consists of amino acids 75–78. These
residues are located between the helices A and B and belong
to the hydrophobic core of the molecule. The C-terminal
part of the molecule (residues 400–432) shows similar cor-
relations with the factor-binding region, which can be pos-
sibly explained by the proximity of these residues to both
the C-terminal end of helix D and the FXa binding exosite.
Most other correlated motions are found between regions
that are close to each other in the tertiary structure.
Regarding the B1 simulation, correlations can be seen in
approximately the same regions, although the coefficients
are lower and a smaller part of the D helix is involved.
Rather than amino acids 75–78, the C-terminal part of helix
A (residues 67–70) shows correlated motions.
In contrast, the ‘mutual information’ matrix computed for
the 1-ms 1NQ9 simulations show significant differences com-
pared to the previous two, although there are also similar-
ities. Here, correlated motions can be observed between the
previously mentioned exosite, the RCL, the C-terminal part of
the protein as well as most amino acids in the region
110–230. This latter region contains helices D, E and F as
well as two strands of beta-sheet A. Residues 75–98, contain-
ing helix B also seems to be involved in the allosteric proc-
esses in this activation state of AT.
A notable conformational change that shows significant
correlation with the ligand RMSD, involves the N-terminal
part of helix D and helix B. The distances between the alpha
carbon atoms of Thr85 (helix B) and His120 (helix D) are
shown in Figures 10 and S23 (supplementary material). Helix
B occupies a central position in the tertiary structure of AT. It
is surrounded by parts of the A, C and D helices and multiple
strands in the ‘A’ beta sheet. Therefore, it could play a signifi-
cant role in the allosteric processes (Figure 10).
In summary, our ‘generalized correlation’ calculations
revealed possible paths of allosteric signal propagation to
the RCL and the binding sites of target proteases. Using the
pentasaccharide-binding trajectories, we could detect correla-
tions involving the helix D that were not present in previ-
ously published ‘conventional’ MD simulations. Based on our
calculations, we can suggest that parts of the A helix and
the C-terminal end of the protein may be involved in the
allosteric processes. Helix B may also contribute to the allo-
steric activation of AT.
4. Conclusion
In the present study, we have studied the early events of
pentasaccharide ligand binding to AT using MD and GAMD
simulations. The binding of a model compound, idraparinux,
was investigated to an X-ray diffraction structure of a ‘native’
AT conformation without a heparin-like activator. We were
able to observe binding modes for the model ligand similar
to that found in the ‘intermediate’ activated AT structure 1NQ9.
Such binding occurred in two independent GAMD trajectories,
with RMSD values as low as 0.6–0.8Å for the ring and intergly-
cosidic atoms of the molecule. Furthermore, we analyzed vari-
ous binding positions of pentasaccharide in multiple MD
trajectories, including some, where the ‘intermediate’ activated
AT structure was selected as starting conformation. Our simula-
tions also provided insights into conformational changes of the
hinge region, the RCL, and the C-terminal part of helix D. The
observed high stability of helix P might indicate that AT confor-
mations with an already formed P helix could play a significant
role in the pentasaccharide binding and conformational activa-
tion. Our ‘generalized correlation’ calculations provided us
details on possible allosteric pathways. However, the modelling
of the complex process of the induced-fit heparin pentasacchar-
ide binding remains a challenging task, even with advanced
sampling techniques such as GAMD.
In summary, our results demonstrate the applicability of
the GAMD method for investigating the binding of a heparin
pentasaccharide to AT. This ligand has several characteristics
that distinguish it from the molecules applied earlier in
related binding studies: it is relatively large, highly flexible
due to its carbohydrate-like structure, and highly negatively
charged. Regarding the potential applications of this method,
future binding studies with various pentasaccharide or even
non-pentasaccharide AT activators could aid the design of
novel AT-dependent anticoagulant drugs. Furthermore, the
biochemical consequences of several pathogenic variants
affecting the heparin binding of AT can be investigated by
this method (Corral, de la Morena-Barrio, & Vicente, 2018;
Dinarvand et al., 2018; Muszbek et al., 2010). Finally, such
simulations could potentially serve as an in silico tool for
investigating interactions between numerous GAG-binding
proteins with diverse biological functions and sulfated
glycosaminoglycans.
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